• 1
    O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81: 148154.
  • 2
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947954.
  • 3
    OPTN/SRTR 2003 Annual report: transplant data 1993–2002. HHS/HRSA/SPB/DOT; UNOS; URREA. Available at Accessed March 2005.
  • 4
    Brandsaeter B, Hockerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, et. al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the Nordic countries. Liver Transpl 2002; 8: 10551062.
  • 5
    Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, et. al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003; 237: 666675; discussion 675–676.
  • 6
    Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005; 11: 594605.
  • 7
    Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et. al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648651.
  • 8
    O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439445.
  • 9
    Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et. al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109119.
  • 10
    Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004; 40: 192197.
  • 11
    Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000; 6: 163169.
  • 12
    Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26: 6268.
  • 13
    Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 1993; 17: 124127.
  • 14
    Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 10501055.
  • 15
    Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992; 33: 98102.
  • 16
    Saibara T, Onishi S, Sone J, Yamamoto N, Shimahara Y, Mori K, et al. Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure. Transplantation 1991; 51: 782786.
  • 17
    Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut 1976; 17: 959964.
  • 18
    Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ, Williams R. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 1995; 21: 101105.
  • 19
    Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002; 359: 558563.
  • 20
    Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005; 11: 10731079.
  • 21
    Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002; 36: 659665.
  • 22
    Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 2006; 55: 98104.
  • 23
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 3: 864871.
  • 24
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 25
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et. al.; United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 12: 9196.
  • 26
    Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KS, Tandon A, et. al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 14481455.
  • 27
    Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998; 43: 13111316.
  • 28
    Jain S, Pendyala P, Varma S, Sharma N, Joshi K, Chawla Y. Effect of renal dysfunction in fulminant hepatic failure. Trop Gastroenterol 2000; 21: 118120.
  • 29
    Ferenci P, Lockwood A, Mullen K, Taster R, Weissenborn K, Blei AT, and the members of the working party. Hepatic encephalopathy—definition, nomenclature, diagnosis and quantification, final report of the working party at the 11th World Congress of Gastroenterology Vienna, 1998. Hepatology 2002; 35: 716721.
  • 30
    Gimson AES, Braude S, Mellon PJ, Canalese J, Williams R. Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 1982; 2: 681683.
  • 31
    Ede R, Gimson AES, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral edema in fulminant hepatic failure. J Hepatol 1986; 2: 4351.
  • 32
    Dhiman RK, Makharia GK, Jain S, Chawla Y. Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. Am J Gastroenterol 2000; 95: 233238.
    Direct Link:
  • 33
    Dhiman RK, Chawla Y, Jain S. Spontaneous bacterial peritonitis and bacteremia in fulminant hepatic failure. Am J Gastroenterol 2000; 95: 21262128.
    Direct Link:
  • 34
    Batra Y, Bhatkal B, Ojha B, Kaur K, Saraya A, Panda SK, Acharya SK. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Bull World Health Organ 2002; 80: 72831.
  • 35
    Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39: 764769.
  • 36
    Aydin C, Berk BS, Fung JJ, Shakil AO. Applicability of MELD scoring system to predict prognosis in patients with acute liver failure [Abstract]. Hepatology 2003; 38(Suppl 1): 554A.
  • 37
    Yantorno SET, Trentadue JJ, Ruf AE, Saa G, Descalzi VI, Andriani OC, et al. The model for end stage liver disease (MELD): a useful tool to access prognosis in fulminant hepatic failure. Liver Transpl 2004; 10: C36.
  • 38
    Rossaro L, Chambers CC, Polson J, Bowlus CL, Hynan LS, Fontana RJ, et al. Performance of MELD in predicting outcome in acute liver failure. Gastroenterology 2005; 128: A705.
  • 39
    Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO End-Stage Liver Disease score, King's College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006; 38: 927929.